Gustavo Chiapinotto Maciel

Há mais de 10 anos potencializamos pessoas e startups que transformam a realidade. Isso é possibilitado com o nosso apoio incondicional às startups do portfólio. Nossos três programas de aceleração são pensados para auxiliar negócios em early stage a crescerem rapidamente, com aporte de capital de risco, acompanhamento próximo, mentorias com líderes experientes, capacitação e muito mais. São mais de 380 investidores, 166 startups aceleradas, R$ 53 milhões investidos e 13 Exits.

Tomorrow Lab is a Venture Builder located in Porto Alegre, Brazil. It creates and launches new companies (startups) with a hands-on approach, acting as institutional founders or co-founders and providing operational support, funding, and strategic guidance from ideation to execution. This model aims to radically increase chances of startups’ success by leveraging resources, expertise and talent from the top-tier professionals.

RS Angels is the angel investor network of Rio Grande do Sul, Brazil, connecting capital, knowledge, and experience to empower high-potential startups. The network designed to give back to the ecosystem — and grow with it.

We are BAT, a leading global consumer goods company driven by a clear purpose: to create A Better Tomorrow™ by Building a Smokeless World. Founded in 1902, we’ve grown into a truly international business, operating across six continents. Our strategic ambition is to become a predominantly smokeless business by 2035**, helping adult smokers transition to scientifically substantiated, reduced-risk*† alternatives. With a powerful portfolio of global brands, a future-focused strategy, and over 45,000 talented people worldwide, we are committed to accelerating Tobacco Harm Reduction and making cigarettes a thing of the past. As a leading FTSE company, our operations span three key regions: 🌍 United States of America 🌍 Americas & Europe (AME) 🌍 Asia Pacific, Middle East & Africa (APMEA) Together, we are building A Better Tomorrow™. * Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive. **Please refer to the cautionary statement contained in the Combined Annual and Sustainability Report 2025 on p.398 for additional information regarding BAT’s future performance: https://www.bat.com/ar/2025/index.html. † Our Vapour product Vuse (including Alto, Solo, Ciro and Vibe), and certain products, including Velo, Grizzly, Kodiak, and Camel Snus, which are sold in the U.S., are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance.